Dear Doctor - Participate in the Survey on psoriatic arthritis " A new survey has found that psoriatic arthritis can have a significant impact on patients' quality of life. The study, which was conducted by the National Psoriasis Foundation (NPF), surveyed more than 3,500 people with psoriatic arthritis and found that the condition can severely affect patients physically, emotionally, and socially.The NPF survey found that psoriatic arthritis can cause pain, fatigue, stiffness, joint damage, and disability. The condition can also lead to depression and anxiety. In addition, the survey found that people with psoriatic arthritis are often socially isolated and have difficulty keeping up with work and daily activities."This survey provides new insights into the real-world impact of psoriatic arthritis," said NPF President Andrew Prince. "It's important for people with psoriatic arthritis to know they are not alone. There are a wide variety of resources available to help manage this complex disease." Participate in Surveys "
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Review looks at potential treatment targets in the tumor microenvironment.
3.
Even when they are not paying attention, children are still learning.
4.
The Benefits of Exercise for Substance Use Disorders.
5.
The top three drugs for multiple myeloma treatment upfront are four.
1.
The New Era of Oncology: Key Updates and Clinical Insights
2.
Everything You Need to Know About RDW-CV: A Comprehensive Guide
3.
Decoding Granular Cell Tumor: What You Need to Know
4.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
5.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
3.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Navigating the Complexities of Ph Negative ALL - Part XI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation